A population study of the pharmacokinetics of felodipine.

British Journal of Clinical Pharmacology

Volumn 31, Issue 1, 1991, Pages 15-24

  Blychert, E ^a   Edgar, B ^a   Elmfeldt, D ^a   Hedner, T ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FELODIPINE;

ADULT; AGE; AGED; ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; BODY WEIGHT; DRUG INTERACTIONS; FELODIPINE; FEMALE; HALF-LIFE; HUMAN; MALE; MIDDLE AGE; POLYMORPHISM (GENETICS); SEX FACTORS;

EID: 0026068773     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1991.tb03852.x     Document Type: Article

References (21)

1. Determination of felodipine in plasma by capillary gas chromatography with electron capture detection
2. Comparison of high‐selectively gas chromatographic methods, including column switching, for the determination of felodipine in plasma
3. Plasma‐concentration effect relationships of intravenous and extended release oral felodipine in hypertensive patients
4. Cytochrome P‐450 dependent oxidation of felodipine—a 1.4‐dihydropyridine—to the corresponding pyridine
5. Absorption, distribution and elimination of felodipine in man
6. Clinical pharmacokinetics of felodipine—a summary
7. Felodipine kinetics in healthy men
8. Characterisation of rat and human liver microsomal cytochrome P‐450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism
9. 14C]felodipine—a new vasodilating drug—in healthy men
10. Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices
11. The 1988 report of the Joint National Committee on detection, evaluation and treatment of high blood pressure
12. Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man
13. Pharmacokinetics of felodipine in elderly hypertensive patients—a comparison with young healthy subjects
14. Pharmacokinetics and biotransformation of 1,4‐dihydropyridine calcium antagonists
15. Pharmacokinetics of felodipine in patients with liver disease
16. The pharmacokinetics of oral nifedipine—a population study
17. Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects
18. Propranolol clearance, an estimation of hepatic blood flow in man
19. Guidelines for the management of mild hypertension: memorandum from a WHO/ISH Meeting
20. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination